Skip to main content
SpringerLink
Log in

Intra-arterial mannitol infusion in the chemotherapy for malignant brain tumors

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Summary

To assess whether therapeutic efficacy is related to the intra-arterial (IA) mannitol infusion prior to ACNU and cisplatin (CDDP) for malignant brain tumors, the survival time of patients with and without mannitol infusion was compared. Ninety-eight patients were randomly assigned to either a mannitol infusion group (group A) or a non-mannitol infusion group (group B); 34 with malignant gliomas (18 in group A and 16 in group B) and 64 with brain metastases (36 in group A and 28 in group B). During radiotherapy, ACNU and CDDP at a dose of 100mg/body were given through the common carotid artery at a rate of 20mg/min. In group A, 50ml of 20% mannitol was injected intra-arterially at a rate of 50ml/min immediately prior to the injection of chemotherapeutic agents.

Of the patients with malignant gliomas, the median survival time (MST) was 52 weeks for all 34 cases, 68 weeks for group A, and 47 weeks for group B. Survival analysis showed no significant differences between the two treatment groups. Of the patients with brain metastases, the MST was 40 weeks for all 64 cases, 47 weeks for group A, and 24 weeks for group B; the survival time was significantly longer in group A as compared to group B (p< 0.05). This study has demonstrated that, for the patients with brain metastases, IA mannitol infusion provided a survival benefit in the IA chemotherapy employing ACNU and CDDP. In contrast, IA mannitol infusion offered no survival benefit to the patients with malignant gliomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sieger HP: Chemotherapy for brain metastases: Recent developments and clinical considerations. Cancer Treat Rev 17: 63–76, 1990

    Google Scholar 

  2. Greig N, Jones H, Cavanagh J: Blood-brain barrier integrity and host responses in experimental metastatic brain tumors. Clin Exp Metast 1: 229–246, 1983

    Google Scholar 

  3. Vick NA, Bigner DD: Microvascular abnormalities in virally-induced canine brain tumors — Structural bases for altered blood-brain barrier function. J Neurol Sci 17: 29–39, 1972

    Google Scholar 

  4. Blasberg RG, Groothuis D, Molnar P: Application of quantitative autoradiographic measurements in experimental brain tumor models. Semin Neurol 1: 203–221, 1981

    Google Scholar 

  5. Groothuis DR, Molnar P, Blasberg RG: Regional blood flow and blood-to-tissue transport in five brain tumor models-Implications for chemotherapy. Prog Exp Tumor Res 27:132–153, 1984

    Google Scholar 

  6. Hasegawa H, Ushio Y, Hayakawa T, Yamada K, Mogami H: Changes of the blood-brain barrier in experimental metastatic brain tumors. J Neurosurg 59: 304–310, 1983

    Google Scholar 

  7. Levin VA, Freeman-Dove M, Landahl HD: Permeability characteristics of brain adjacent to tumors in rats. Arch Neurol 32: 785–791, 1975

    Google Scholar 

  8. Neuwelt EA, Howieson J, Frenkel EP, David Specht H, Weigel R, Buchan CG, Hill SA: Therapeutic efficacy of multiagent chemotherapy with drug delivery enhancement by blood-brain barrier modification on glioblastoma. Neurosurgery 19: 573–582, 1986

    Google Scholar 

  9. Hasegawa H, Shapiro WR, Posner JB: Chemotherapy of experimental metastatic brain tumors in female wister rats. Cancer Res 39: 2691–2697, 1979

    Google Scholar 

  10. Bullard DE, Bigner DD: Blood-brain barrier disruption in immature Fischer 344 rats. J Neurosurg 60: 743–750, 1984

    Google Scholar 

  11. Chiueh CC, Sun CL, Kopin IJ, Fredericks WR, Rapoport SI: Entry of [3H]norepinephrine, [125I]albumin and evans blue from blood into brain following unilateral osmotic opening of the blood-brain barrier. Brain Res 145:291–301, 1978

    Google Scholar 

  12. Houthoff HJ, Go KG, Gerrits PO: The mechanisms of blood-brain barrier impairment by hyperosmolar perfusion: an electron cytochemical study comparing exogenous HRP and endogenous antibody to HRP as tracers. Acta Neuropathol (Berl) 56: 99–112, 1982

    Google Scholar 

  13. Rapoport SI, Fredericks WR, Ohno K, Pettigrew KD: Quantitative aspects of reversible osmotic opening of the blood-brain barrier. Am J Physiol 235:421–431, 1980

    Google Scholar 

  14. Sterrett PR, Thompson AM, Chapman AL, Matzke HA: The effect of hyperosmolarity on blood-brain barrier. A morphological and physiological correlation. Brain Res 77: 281–295, 1974

    Google Scholar 

  15. Neuwelt EA, Barnett PA, Frenkel EP: Chemotherapeutic agent permeability to normal brain and delivery to avian sarcoma virus-induced brain tumors in the rodent: Observations on problems of drug delivery. Neurosurgery 14:154–160, 1984

    Google Scholar 

  16. Neuwelt EA, Specht HD, Howieson J, Haines JE, Bennett MJ, Hill SA, Frenkel EP: Osmotic blood-brain barrier modification: Clinical documentation by enhanced CT scanning and/or radionuclide brain scanning. AJNR 4: 907–913, 1983

    Google Scholar 

  17. Hori T, Muraoka K, Saito Y, Sasahara K, Inagaki H, Inoue Y, Adachi S, Anno Y: Influence of modes of ACNU administration on tissue and blood drug concentration in malignant brain tumors. J Neurosurg 66: 372–378, 1987

    Google Scholar 

  18. Miyagami M, Tsubokawa T, Tazoe M, Kagawa Y: Intra-arterial ACNU chemotherapy employing 20% mannitol osmotic blood-brain barrier disruption for malignant brain tumor. Neurol Med Chir (Tokyo) 30: 582–590, 1990

    Google Scholar 

  19. Hiesiger EM, Voorthies RM, Basler GA, Shapiro WR, Posner JB: Opening the blood-brain and blood-tumor barriers in experimental rat brain tumors: the effect of intracarotid hyperosmolar mannitol on capillary permeability and blood flow. Ann Neurol 19: 50–59, 1986

    Google Scholar 

  20. Inoue T, Fukui M, Nishio S, Kitamura K, Nagara H: Hyperosmotic blood-brain barrier disruption in brains of rats with an intracerebrally transplanted RG-C6 tumor. J Neurosurg 66: 256–263, 1987

    Google Scholar 

  21. Nakagawa H, Groothuis D, Blasberg RG: The effect of graded hypertonic intracarotid infusions on drug delivery to experimental RG-2 gliomas. Neurology 34:1571–1581, 1984

    Google Scholar 

  22. Warnke PC, Blaberg RG, Groothuis DR: The effect of hyperosmotic blood-brain barrier disruption on blood-to-tissue transport in ENU-induced gliomas. Ann Neurol 22: 300–305, 1987

    Google Scholar 

  23. Roosen N, Kiwit JCW, Lins E, Schirmer M, Bock WJ: Adjuvant intraarterial chemotherapy with Nimustine in the management of World Health Organization grade 4 gliomas of the brain. Cancer 64:1984–1994, 1989

    Google Scholar 

  24. Feun LG, Wallace S, Stewart DJ, Chuang VP, Yung WKA, Leavens ME, Burgess MA, Savaraj N, Benjamin RS, Young SE, Tang RA, Handel S, Mavligit G, Fields WS: Intracarotid infusion of cis-diamminedichloroplatinum in the treatment of recurrent malignant brain tumors. Cancer 54: 794–799, 1984

    Google Scholar 

  25. Mahaley MS Jr, Hipp SW, Dropcho EJ, Bertsch L, Cush S, Tirey T, Gillespie GY: Intracarotid cisplatin chemotherapy for recurrent gliomas. J Neurosurg 70:371–378, 1989

    Google Scholar 

  26. Kornblith PL, Walker M: Chemotherapy for malignant gliomas. J Neurosurg 68:1–17, 1988

    Google Scholar 

  27. Neuwelt EA, Barnett PA, Glasberg M, Frenkel EP: Pharmacology and neurotoxicity of cis-diamminedichloroplatinum, bleomycin, 5-fluorouracil, and cyclophosphamide administration following osmotic blood-brain barrier modification. Cancer Res 43: 5278–5285, 1983

    Google Scholar 

  28. Mahaley MS Jr, Whaley RA, Blue M, Bertsch L: Central neurotoxicity following intracarotid BCNU chemotherapy for malignant gliomas. J Neurooncol 3: 297–314, 1986

    Google Scholar 

  29. Fenstermacher JD, Cowles AL: Therapeutic limitation of intracarotid infusions in brain tumor chemotherapy. Cancer Treat Rep 61: 519–526, 1977

    Google Scholar 

  30. Pappius HM, Savaki HE, Fieschi C, Rapoport SI, Sokoloff L: Osmotic opening of the blood-brain barrier and local cerebral glucose utilization. Ann Neurol 5: 211–219, 1979

    Google Scholar 

  31. Suzuki M, Iwasaki Y, Yamamoto T, Konno H, Kudo H: Sequelae of the osmotic blood-brain barrier opening in rats. J Neurosurg 69: 421–128, 1988

    Google Scholar 

  32. Tomiwa K, Hazama F, Mikawa H: Reversible osmotic opening of the blood-brain barrier. Prevention of tissue damage with filtration of the perfusate. Acta Pathol Jpn 32:427–435, 1982

    Google Scholar 

  33. Burger PC, Heinz ER, Shibata T, Kleihues P: Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg 68: 698–704, 1988

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Chiba Cancer Center Hospital, Chiba, Japan

    Yasuo Iwadate, Hiroki Namba, Takashi Saegusa & Kanji Sueyoshi

Authors
  1. Yasuo Iwadate
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiroki Namba
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Takashi Saegusa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kanji Sueyoshi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Iwadate, Y., Namba, H., Saegusa, T. et al. Intra-arterial mannitol infusion in the chemotherapy for malignant brain tumors. J Neuro-Oncol 15, 185–193 (1993). https://doi.org/10.1007/BF01053940

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01053940

Key words

Search

Navigation